Last reviewed · How we verify

NCT06267599

Bladder Suture in Uterus-Sparing Surgery and Hysterectomy for Placenta Percreta

Completed Last updated 20 February 2024
What this trial tests

trial testing ACAR-Style Bladder Suture in Placenta Percreta in 81 participants. Completed in 1 January 2024.

Timeline
1 September 2023
Primary endpoint
1 December 2023
1 January 2024

Quick facts

Lead sponsorNecmettin Erbakan University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment81
Start date1 September 2023
Primary completion1 December 2023
Estimated completion1 January 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Necmettin Erbakan University

Who can join

Adults 18 to 50, female only, with Placenta Percreta or Bladder Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to evaluate the short-term and long-term complications of placenta percreta with bladder invasion. This evaluation focuses on cases where bladder dissection and ACAR-style bladder sutures were applied in cases of placenta percreta with bladder invasion that underwent uterine-sparing surgery or hysterectomy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Necmettin Erbakan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06267599.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing